T

The Neurological Institute, PA | Charlotte, NC

Research site

(Unclaimed)

Location

2607 East 7th Street, Suite 200, Charlotte, North Carolina, United States of America

Site insights

Top conditions

Top treatments

YKP3089

Nipocalimab

VX15/2503

Fampridine

Droxidopa

SAR441344

Eslicarbazepine Acetate

Frexalimab

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 8 total trials

Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis (FREXALT)

The purpose of each study is to independently measure the annualized relapse rate (ARR) with administration of frexalimab compared to a daily oral do...

Enrolling

Multiple Sclerosis

Drug: Activated charcoal

Drug: Cholestyramine

Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

The main purpose of this study is to evaluate the safety and efficacy of nipocalimab compared to placebo in delaying relapse in adults with chronic i...

Enrolling

Polyradiculoneuropathy, Chronic Inflammatory Demyelinating

Drug: Nipocalimab

Drug: Placebo